Breaking News
Research on Alzheimer´s Early detection of Alzheimer’s biomarkers
Pressure BioSciences Announces First Manufacturing Build Completely Sold Out for Revolutionary UST System for Processing Hemp-Derived Cannabinoid Oil into Stable, Water-Soluble Nanoemulsions
Seven Bridges Completes Independent Examinations for SOC2, SOC3 and HIPAA
Latest Blogs
Table of Contents
Volume 29, Issue 4
Articles
IBO Spring 2020 Business Climate Survey: Laboratory Tool Companies React to COVID-19
COVID-19 Negatively Impacts IBO Indexes’ First Quarter Performances
Sequencing’s Role in Addressing COVID-19
Executive Briefings
Roche Makes Nanopore Sequencing Acquisition
Agilent Shuts Down Sequencer Development
Calorimeter Company Acquired
PacBio Sued in China
Financial
First Quarter Results: Agilent Technologies, Bio-Techne, Bruker, MilliporeSigma and QIAGEN
IBO Stock Indexes Continue to Improve in May
Market Profile
Raman Microscopy
Industry Watch
Biotechnology
Energy
Clinical
Region Watch
China
Germany
South Korea
News
MS & LC/MS
Surface Science
Life Science Consumables
Informatics
NIH Lays Out Vision for Nutrition Research
The National Instituts of Health (NIH) has released the “2020–2030 Strategic Plan for NIH Nutrition Research,” developed by the NIH Nutritional Research Task Force. The report calls for research investments in Precision Nutrition. Unlike personalized nutrition or nutrigenomcis, Precision Nutrituion encompasses both internal and external contributions: diet, genetics, physical health, microbiome, metabolism, dietary habits, activity […]
A Continuous Flow of Investments in COVID-19 R&D
In the IBO blog’s fourth look at coronavirus-related R&D funding, the focus is on announcements made in May. Governments continue to make large commitments, with funding ultimately designated for universities, research institutes, the private sector, and infectious disease research organizations that will coordinate efforts to funnel money to all three sectors. These organizations include CEPI […]
COVID-19 and RNA Prep
Clinical diagnostic testing has been a major bottleneck throughout the global response to the COVID-19 pandemic, with severe shortages of testing reagents, lack or slow adaptation of existing infrastructure to administer tests, and very rapidly growing demand that is outpacing supply. The extraordinary demand for COVID-19 testing has strained the production capabilities of vendors in […]
The Growing Potential of the Cell and Gene Therapy Market in 2020
The development of cell and gene therapies has become an essential component of cancer and genetic disease research and treatment. Consequently, regulatory approvals for cell and gene therapy have begun to increase globally. As a result, cell and gene therapy research has expanded into other areas of medicine, such as treatments for autoimmune and dermatological diseases.
A Steady Stream of New Funding for COVID-19 R&D
This is the third of IBO’s review of R&D investments related to COVID-19 (see March 27 and April 17). The outbreak has triggered a wide range of responses spanning immediate and long-term solutions. For R&D, spending priorities range from areas such as new diagnostic approaches and vaccine development to basic research in fields such as […]